The effect of paroxetine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects.
| Publicado en: | European Journal of Clinical Pharmacology Vol. 64; no. 6; pp. 605 - 610 |
|---|---|
| Autores principales: | , , , , |
| Formato: | equations & formulas research tables/charts Journal Article |
| Publicado: |
Springer Nature
Jun2008
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105650129&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 105650129 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00316970 NP9 jtl: European Journal of Clinical Pharmacology issn: 00316970 maglogo: N pubinfo: dt: Jun2008 vid: 64 iid: 6 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 105650129 2009909955 10.1007/s00228-008-0472-z NLM18401578 105650129 ppf: 605 ppct: 5 formats: fmt: @attributes: type: P tig: atl: The effect of paroxetine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects. aug: au: Kadokura T den Adel M Krauwinkel WJJ Takeshige T Nishida A affil: Clinical Pharmacology, Astellas Pharma Inc., 3-17-1, Hasune, Itabashi-ku, Tokyo 174-8612, Japan sug: subj: Antiemetics Pharmacokinetics Paroxetine Therapeutic Use Serotonin Antagonists Therapeutic Use Adult Analysis of Variance Confidence Intervals Descriptive Statistics Drug Interactions Middle Age White Persons Human Adult: 19-44 years Middle Aged: 45-64 years pubtype: Academic Journal doctype: equations & formulas research tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|